Delivery Order SPE2DR25D2100-SPE2DR26FA0CV
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,024.20 to AmerisourceBergen Drug Corp for the supply of Quviviq 25 mg tablets (30-count package) under a firm fixed-price contract type. This delivery order, issued on October 22, 2025, represents a non-competitive, non-set-aside award and will be performed at the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of October 23, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of Quviviq 25 mg tablets in a quantity of 30s. This is a firm fixed price delivery order with a ceiling value of $1,662.22, representing a non-set-aside competitive award. The contract has an ultimate completion date of November 5, 2025, with performance to be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $1,181.80 to AmerisourceBergen Drug Corp for QUVIVIQ 50 mg tablets (30-count packaging) on November 14, 2025, with an ultimate completion date of November 17, 2025. This non-competitive, firm fixed-price delivery order was issued without a set-aside designation and represents a pediatric insomnia treatment supply to support federal medical procurement needs. The contract performance will be executed from the contractor's Corporate...
- The Defense Logistics Agency awarded a delivery order valued at $1,163.41 to AmerisourceBergen Drug Corp for 30 tablets of Quviviq 25 mg on September 5, 2025, with an ultimate completion date of September 8, 2025. This firm fixed price contract represents a non-competitive award and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Quviviq is a prescription insomnia medication, reflecting the Department of Defense's ongoing pharmaceutical supply needs for...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Quviviq 50 mg tablets (30-count packaging) under a firm fixed-price contract valued at $2,705.59, with completion targeted for August 25, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a maximum value of $999,999,999.00 and extends...
- The Defense Logistics Agency awarded a $123,140 delivery order to Amerisourcebergen Drug Corporation for 50mg Quviviq tablets. Under the firm fixed price contract, Amerisourcebergen will deliver 30 boxes of the insomnia medication to a facility in Conshohocken, Pennsylvania by August 7, 2023 to support the Department of Defense's medical supply needs. As a leading distributor of pharmaceuticals and medical supplies for federal agencies, Amerisourcebergen will utilize its existing distribution...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,712.87 to AmerisourceBergen Drug Corp on November 5, 2025, for the supply of Quviviq 25 mg tablets (30-count package). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of November 6, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 22, 2025, for the supply of Quviviq 25 mg tablets in a quantity of 30 units, with a ceiling value of $1,268.29. This is a firm fixed-price delivery order with an ultimate completion date of October 23, 2025, and represents a non-set-aside competitive award. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $369,000 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 50mg QUVIVIQ tablets. Under this order, Amerisourcebergen will deliver 30 units of the prescribed sleep medication to a facility in Conshohocken, Pennsylvania by June 21, 2023 to support the Department of Defense's medical supply needs. As a leading pharmaceutical distributor, Amerisourcebergen routinely fulfills delivery orders under the DLA's Prime Vendor program to stock...
- The Defense Logistics Agency awarded a delivery order valued at $1,367.56 to AmerisourceBergen Drug Corp for QUVIVIQ 25 mg tablets (30-count supply) on August 11, 2025, with an ultimate completion date of August 12, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a continuation of the vendor's established pharmaceutical supply relationship with the federal government. The product will be delivered to the place of performance in...
- SPE2DR25D2100Indefinite Delivery Contract
- SPE2DR25D2100-SPE2DR26FA0CVDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,073.34 to AmerisourceBergen Drug Corp for the supply of QUVIVIQ 25 mg tablets (30-count package), a pharmaceutical product used in the treatment of insomnia. This firm fixed-price delivery order, issued on November 14, 2025, is scheduled for completion by November 17, 2025, and will be delivered to a location in Conshohocken, Pennsylvania. The award utilized no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement serving military and veteran healthcare systems. This delivery order is executed under AmerisourceBergen Drug Corp's prime indefinite delivery contract (IDC) with DLA Troop Support Medical, valued at $999.99 billion and extending through December 2026. This comprehensive global pharmaceutical support vehicle enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. The contract serves various federal customers including the Defense Health Agency and U.S. Coast Guard, positioning AmerisourceBergen as a key component of the federal medical supply chain infrastructure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 11/14/25 |